Indigenous Peoples encounter numerous challenges in exercising their right to health. Lorna Rothery discussed the importance of collaborative and culturally sensitive approaches with Dr Sandra Del Pino, Advisor on Cultural Diversity at PAHO.
Phase Three data from the UK trial shows that Novavax still works powerfully against the UK mutation, with a less intense impact on the South African mutation at 60%.
Hugh Bettesworth, CEO, Mirada Medical, explores how AI autocontouring technology can help tackle the cancer care backlog as a result of the COVID-19 pandemic.
New data from the REACT study finds that the rising infection rate has steadied a little, but there is no "sharp drop in infections" as in the first wave and the R is still high.
With eyewitness awareness of how six million Jewish people lost their lives, aging Holocaust survivors have carried an impossible burden - now, researchers are attempting to document the lifelong impact of trauma.
AstraZeneca CEO Pascal Soriot spoke to Antonello Guerrera about the ongoing vaccine feud - with the Commission receiving 60% less than expected, raising tense questions about why.
Prime Minister Boris Johnson announced that he had done "everything possible" to prevent 100,000 COVID deaths, as the UK witnesses 50,099 fatalities in the space of 79 days.
The company announced that their current vaccine can handle the South African COVID mutation - with plans to create an "additional booster dose" to see if they can create specific protections against emerging variants.
Researchers are looking into Twitter whistle-blowers who raised concerns about suspicious 'pneumonia' cases, one month before the Chinese Government announced the existence of COVID-19.
Tomorrow (26 January) the COVID 'O' meeting is expected to be a moment of decision-making about border policy, as the more infectious South African and Brazilian COVID mutations continue to circulate.
EU leaders are investigating why AstraZeneca are not following through with the pre-agreed number of vaccines for the Member States - taking a 60% cut to the expected amount.
Data from Queen Mary University of London suggests that Asian COVID patients are 1.5 times as likely to die as white patients - with Black patients 1.3 times more likely to die.
Paul Bensley, Managing Director at X-on, discusses how patient communications could be the only way to solve complex logistical considerations for mass vaccination.
Researchers have found that the Ganges River could be for depositing three billion microplastic particles into the Bay of Bengal daily - impacting 655 million people.
